Stock markets rallied after Donald Trump’s victory in the US presidential election, pushing dozens of names into overvalued ...
Minter-Jordan: We consider ourselves a fierce advocate and a wise friend. That's the role we play with our membership. We make sure we represent the needs of the 38 million members AARP has in terms ...
Higher tariffs on eurozone exports to the U.S. could weaken economic growth in the eurozone, but would have a mixed effect on inflation in the currency area, a senior official at the European Central ...
The USDA said that for the week ended Nov. 7, corn export sales landed at 1.32 million metric tons in the 2024/25 marketing year. That's down 53% from the previous week, and on the low side of ...
The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply lower Friday, after President-elect Donald Trump named Robert F. Kennedy Jr.
Alibaba is one of the most mentioned companies in the U.S. across all news items in the past 12 hours, according to Factiva data. Alibaba's adjusted earnings per American-listed share were 15.06 yuan ...
Alignment Healthcare shares were down 14% at $11.10 after the company said it has entered into privately negotiated subscription agreements with certain investors to which it will issue $330 million ...
Older adults ranging from age 56 to 71 venture into the dating arena in a new Netflix (NFLX) docuseries executive-produced by Michelle Obama that aims to showcase mature dating in a more realistic way ...
On a holding company level, Power Corporation has adequate liquidity, and its net debt accounts for less than 15% of the value of its assets. Given the moderate amount of leverage and the cash flows ...
Award-winning technical analyst is wary about Nvidia heading into next week's earnings The stock market has been charging along for months. Perhaps not for long. Tom DeMark, an award-winning technical ...
Bavarian Nordic, a maker of the mpox vaccine, on Friday said the incoming Trump administration may present opportunities even after the announcement that noted vaccine skeptic Robert F. Kennedy Jr.